Author:
Pavanello Marco,Piro Liliana,Roggero Arianna,Rossi Andrea,Cataldi Matteo,Piatelli Gianluca
Abstract
Abstract
Introduction
Encephalocraniocutaneous lipomatosis (ECCL) is a rare congenital syndrome with complex skin, eye, and central nervous system (CNS) symptoms. Diagnosis and treatment are challenging due to its rarity and diverse manifestations. It often involves issues like porencephalic cysts, cortical atrophy, and low-grade gliomas in the CNS, resulting in developmental delays. The spinal cord is frequently affected, leading to problems like medullary compression and radiculopathy, causing back pain and sensory/motor deficits. Surgical interventions are reserved for symptomatic cases to address hydrocephalus or alleviate spinal lipomas. This article reviews a case series to assess surgical risks and neurological outcomes.
Case series
We present a case series ECCL, focusing on the diffuse lipomatosis of the spinal cord and the intricate surgical procedures involved. A multi-stage surgical approach was adopted, with continuous neuromonitoring employed to safeguard motor pathways. We discuss clinical characteristics, imaging studies, and indications for neurosurgical interventions.
Discussion
ECCL is a complex syndrome. Diagnosis is challenging and includes clinical evaluation, neuroimaging, and genetic testing. Treatment targets specific symptoms, often requiring surgery for issues like lipomas or cerebral cysts. Surgery involves laminectomies, spinal fusion, and motor pathway monitoring. Thorough follow-up is crucial due to potential CNS complications like low-grade gliomas. Hydrocephalus occurs in some cases, with endoscopic third ventriculostomy (ETV) preferred over ventriculoperitoneal shunt placement.
Conclusion
Neurosurgery for ECCL is for symptomatic cases. ETV is preferred for hydrocephalus, while the treatment for lipoma is based on the presence of symptoms; the follow-up should assess growth and prevent deformities.
Funder
Università degli Studi di Genova
Publisher
Springer Science and Business Media LLC
Subject
Neurology (clinical),General Medicine,Pediatrics, Perinatology and Child Health
Reference14 articles.
1. Biesecker LG (2006) The challenges of Proteus syndrome: diagnosis and management. Eur J Hum Genet 14(11):1151–1157
2. Klein S, Hamerschmidt R, Waissmann W (2009) Encephalocraniocutaneous lipomatosis. Revista brasileira de neurologia (Rev Bras Neurol) 45(3):69–72
3. Herrera-Gómez Á, Carrasco-Rozas A, Sánchez-Romero F, Herrera-Gómez FJ (2019) Encephalocraniocutaneous lipomatosis: clinical, neuroimaging, and genetic features. A review of 32 cases. Neurologia 34(1):46–54
4. Karaman ZF, Özüdoğru ŞE (2021) Encephalocraniocutaneous lipomatosıs (Haberland syndrome) in a newborn baby: a case report with review of literature. Child’s nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery 37(12):3951–3955. https://doi.org/10.1007/s00381-021-05099-7
5. Moog U, Jones MC, Bird LM et al (2005) Encephalocraniocutaneous lipomatosis plus: a syndrome including intracranial lipomas, uveal colobomas, and complex vascular anomalies. Report of two patients and review of the literature. Neuropediatrics 36(6):347–352